Back
Solid Biosciences 10K Form
Sell
19
SLDB
Solid Biosciences
Last Price:
5.87
Seasonality Move:
25.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | SLDB/Solid Biosciences Quarterly |
| 2020-05-07 | 10Q | SLDB/Solid Biosciences Quarterly |
| 2020-03-13 | 10K | SLDB/Solid Biosciences Annual |
| 2020-03-12 | 10K | SLDB/Solid Biosciences Annual |
| 2019-11-12 | 10Q | SLDB/Solid Biosciences Quarterly |
| 2019-08-14 | 10Q | SLDB/Solid Biosciences Quarterly |
Receive SLDB News And Ratings
See the #1 stock for the next 7 days that we like better than SLDB
SLDB Financial Statistics
Sales & Book Value
| Annual Sales: | $8.09M |
|---|---|
| Cash Flow: | $-23.72M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.29 |
| Price / Book: | 1.4 |
Profitability
| EPS (TTM): | -3.04000 |
|---|---|
| Net Income (TTM): | $-102.44M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Solid Biosciences Earnings Forecast
Key Solid Biosciences Financial Ratios
- Per Share Earnings over the last 9 years have been positive in 4 years.
Solid Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SLDB |
| CUSIP: | 83422E |
| Website: | solidbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SLDB Technical Analysis vs Fundamental Analysis
Sell
19
Solid Biosciences (SLDB)
is a Sell
Is Solid Biosciences a Buy or a Sell?
-
Solid Biosciences stock is rated a Sell
The current Solid Biosciences [SLDB] share price is $5.87. The Score for SLDB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.